Antiangiogenic therapy for liver metastasis of gastrointestinal malignancies

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 6, Issue 1, 1999, Pages 1-6

  Konno, Hiroyuki ^a   Tanaka, Tatsuo ^a   Baba, Megumi ^a   Kanai, Toshikazu ^a   Nakamura, Satoshi ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis inhibitors; Colon cancer; Gastric cancer; Hepatic metastasis

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; ENDOTHELIAL CELL GROWTH FACTOR; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN DERIVATIVE; THALIDOMIDE;

ANIMAL; DRUG EFFECT; FEMALE; GASTROINTESTINAL TUMOR; HUMAN; LIVER; LIVER TUMOR; MALE; METASTASIS; MOUSE; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROGNOSIS; REVIEW; VASCULARIZATION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ENDOTHELIAL GROWTH FACTORS; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKINS; LIVER; LIVER NEOPLASMS; MALE; MICE; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; THALIDOMIDE;

EID: 0032615843     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005340050077     Document Type: Article

References (30)

1. Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? (editorial). J Natl Cancer Inst 82:4-6
2. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J (1994) Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79:315-328
3. Crowley NJ, Seigler HF (1992) Relationship between disease-free interval and survival in patients with recurrent melanoma. Arch Surg 127:1303-1308
4. Demicheli R, Terenziani M, Valagussa P, Moloterni A, Zambetti M, Bonadonna G (1994) Local recurrences following mastectomy: Support for the concept of tumor dormancy. J Natl Cancer Inst 86:45-48
5. Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of angiogenic switch during tumorigenesis. Cell 86:353-364
6. Dong Z, Kumar R, Yang X, Fidler IJ (1997) Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell 88:801-810
7. Lijnen HR, Ugwu F, Bini A, Cillen D (1998) Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3). Biochemistry 37:4699-4702
8. Patterson BC, Sang QA (1997) Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J Biol Chem 272:28823-28825
9. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J (1997) Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277-285
10. Boehm T, Folkman J, Browder T, O'Reilly MS (1997) Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 390:404-405
11. Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H, Folkman J (1990) Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348:555-577
12. Yamaoka M, Yamamoto T, Masaki T, Ikeyama S, Sudo K, Fujita T (1993) Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetylcarbamoyl)fumagillol (TNP-470; AGM-1470). Cancer Res 53: 4262-4267
13. Yanase T, Tamura M, Fujita K, Kodama S, Tanaka K (1993) Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo. Cancer Res 53:2566-2570
14. Kudelka AP, Verschraegen CF, Loyer E (1998) Complete remission of metastatic cervical cancer with the angiogenesis inhibitor TNP-470. New Engl J Med 338:991-992
15. Griffith EC, Su Z, Turk BE, Chen S, Chang Y-H, Wu Z, Biemann K, Liu JO (1997) Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin. Chemistry Biology 4:461-471
16. Tanaka T, Konno H, Matsuda I, Nakamura S, Baba S (1995) Prevention of hepatic metastasis of human colon cancer by angiogenesis inhibitor TNP-470. Cancer Res 55:836-839
17. Fu X, Resterman JM, Monosov A, Hoffman RM (1991) Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens. Proc Natl Acad Sci USA. 88:9345-9349
18. Furukawa T, Fu X, Kubota T, Watanabe M, Kitajima M, Hoffman RM (1993) Nude mouse metastatic models of human stomach cancer constructed using orthotopic implantation of histologically intact tissue. Cancer Res 53:1204-1208
19. Ahmed MH, Arai T, Konno H, Nahar L, Tanaka T, Izumiyama N, Takubo K, Nakamura S, Baba S (1997) Jpn J Cancer Res 88:977-981
20. Toi M, Inada K, Suzuki H, Tominaga T (1996) Tumor angiogenesis in breast cancer: Its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Research and Treatment 36:193-204
21. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM (1995) Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55:3964-3968
22. Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, Sawada T, Sowa M (1996) Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 77:858-863
23. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362(6423):841-844
24. Warren RS, Yuan H, Matli MR, Gillett NA, Ferrara N (1995) Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental hepatic metastasis. J Clin Invest 95:1789-1797
25. Asano M, Yukita A, Matsumoto T, Kondo S, Suzuki H (1995) Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor 121. Cancer Res 55:5296-5301
26. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A (1994) Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 1367:576-579
27. Borgstrom P, Hillan KJ, Sriramarao P, Ferrara N (1996) Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: Novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res 56:4032-4039
28. Kanai T, Konno H, Tanaka T, Baba M, Matsumoto K, Nakamura S, Yukita A, Asano M, Suzuki H, Baba S (1998) Anti-tumor and anti-metastatic effects of human vascular endothelial growth factor neutralizing antibody on human colon and gastric carcinoma xenotransplanted orthotopically into nude mice. Int J Cancer 77:933-936
29. Melnyk O, Shuman MA, Kim KJ (1996) Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth. Cancer Res 56:921-924
30. Konno H, Tanaka T, Matsuda I, Kanai T, Maruo Y, Nishino N, Nakamura S, Baba S (1995) Comparison of the inhibitory effect of the angiogenesis inhibitor, TNP-470, and mitomycin C (MMC) on the growth and liver metastasis of human colon cancer. Int J Cancer 61:268-271